{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"22"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"35"}],"units":"Participants"}],"description":"Patients deemed \"alive and well\" at follow-up timepoint later than 1-year post-transplantation","groups":[{"description":"Conditioning with Alemtuzumab, busulfan and fludarabine followed by allogeneic hematopoietic cell transplant.","id":"OG000","title":"Single Arm - Transplant Pre-conditioning Per Study Protocol"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"1 year post-transplantation","title":"Disease-free Survival With Correction of Disease at One Year Post Transplantation","type":"SECONDARY","unitOfMeasure":"participants"}